Garrett I R, Whitehouse M W, Vernon-Roberts B, Brooks P M
J Rheumatol. 1985 Dec;12(6):1079-82.
We evaluated the antiarthritic activity of gold sodium aurothiomalate (GSTM) and auranofin (AF) against experimental polyarthritis induced in 3 rat strains using 3 different adjuvants. These 2 gold drugs were found to either stimulate, inhibit or have no effect upon the development of arthritis, dependent upon the rat strain and/or the adjuvant used. The ambivalent antiarthritic activities of GSTM and AF did not appear to be associated with any variations in serum gold levels. These results highlight the need for caution in studying gold drugs using the adjuvant polyarthritic model in the rat and, if used, the need to define clearly the strain/adjuvant/gold drug combination. Within these constraints however, our findings support the concept that GSTM and AF have different mechanisms of action.
我们评估了硫代苹果酸金钠(GSTM)和金诺芬(AF)对使用3种不同佐剂在3种大鼠品系中诱导的实验性多关节炎的抗关节炎活性。发现这两种金药物对关节炎的发展要么有刺激作用,要么有抑制作用,要么没有影响,这取决于大鼠品系和/或所使用的佐剂。GSTM和AF的矛盾抗关节炎活性似乎与血清金水平的任何变化无关。这些结果强调了在大鼠佐剂性多关节炎模型中研究金药物时需要谨慎,如果使用该模型,需要明确界定品系/佐剂/金药物组合。然而,在这些限制范围内,我们的研究结果支持GSTM和AF具有不同作用机制这一概念。